RISK OF EARLY AND LATE CARDIOTOXICITY IN DOXORUBICIN-TREATED BREAST-CANCER PATIENTS

被引：0
|
作者：
BUZDAR, A [1 ]
SMITH, T [1 ]
MARCUS, C [1 ]
BLUMENSCHEIN, G [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1983年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [1] Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study
    Chu, Jian
    Tung, Lillian
    Attalah, Issam
    Wei, Changli
    Cobleigh, Melody
    Rao, Ruta
    Feinstein, Steven B.
    Usha, Lydia
    Banach, Kathrin
    Reiser, Jochen
    Okwuosa, Tochukwu M.
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [2] Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study
    Jian Chu
    Lillian Tung
    Issam Atallah
    Changli Wei
    Melody Cobleigh
    Ruta Rao
    Steven B. Feinstein
    Lydia Usha
    Kathrin Banach
    Jochen Reiser
    Tochukwu M. Okwuosa
    Cardio-Oncology, 10
  • [3] ONYCHOLYSIS IN DOXORUBICIN-TREATED PATIENTS
    CURRAN, CF
    ARCHIVES OF DERMATOLOGY, 1990, 126 (09) : 1244 - 1244
  • [4] Primary Prevention of Subclinical Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin
    Chung, Woo-Baek
    Ihm, Sang Hyun
    Youn, Ho-Joong
    Chae, Byung Joo
    Song, Byung-Joo
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S202 - S203
  • [5] The paracrine effects of fibroblasts on Doxorubicin-treated breast cancer cells
    Fourie, Carla
    Davis, Tanja
    Kriel, Jurgen
    Engelbrecht, Anna-Mart
    EXPERIMENTAL CELL RESEARCH, 2019, 381 (02) : 280 - 287
  • [6] Early Increases in Biomarkers Predict Subsequent Cardiotoxicity in Breast Cancer Patients Treated With Doxorubicin, Taxanes, and Trastuzumab
    Putt, Mary
    Ky, Bonnie
    Sawaya, Heloisa
    French, Benjamin
    Januzzi, James L.
    Sebag, Igal
    Planas, Juan
    Cohen, Victor
    Blanchs, Jose
    Carver, Joseph
    Wiegers, Susan
    Martin, Randolph P.
    Picard, Michael
    Gerstzen, Robert
    Halpern, Elkan
    Passeri, Jonathan
    Irene, Kuter
    Scherrer-Crosbie, Marielle
    CIRCULATION, 2013, 128 (22)
  • [7] Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (vol 10, 3, 2024)
    Chu, Jian
    Tung, Lillian
    Atallah, Issam
    Wei, Changli
    Cobleigh, Melody
    Rao, Ruta
    Feinstein, Steven B.
    Usha, Lydia
    Banach, Kathrin
    Reiser, Jochen
    Okwuosa, Tochukwu M.
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [8] Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status
    Jahangier, Shahzaad Khadeem
    Qamar, Rubina
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
    Thompson, K. A.
    BREAST DISEASES, 2015, 26 (03): : 257 - 259
  • [10] Predictors of Cardiotoxicity in Early Breast Cancer Patients Treated with Doxorubicin and/or Trastuzumab: Implications of Race/Ethnicity and Insurance Status
    Jahangier, Shahzaad
    Qamar, Rubina
    Thohan, Vinay
    Singh, Maharaj
    Liao, Yunqi
    Weese, James
    Khandheria, Bijoy
    Kamke-Jordan, Anna
    CANCER RESEARCH, 2024, 84 (09)
12345